These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 28042576)
21. A Monovalent and Trivalent MVA-Based Vaccine Completely Protects Mice Against Lethal Venezuelan, Western, and Eastern Equine Encephalitis Virus Aerosol Challenge. Henning L; Endt K; Steigerwald R; Anderson M; Volkmann A Front Immunol; 2020; 11():598847. PubMed ID: 33542715 [TBL] [Abstract][Full Text] [Related]
22. Exposing cryptic epitopes on the Venezuelan equine encephalitis virus E1 glycoprotein prior to treatment with alphavirus cross-reactive monoclonal antibody allows blockage of replication early in infection. Calvert AE; Bennett SL; Hunt AR; Fong RH; Doranz BJ; Roehrig JT; Blair CD Virology; 2022 Jan; 565():13-21. PubMed ID: 34626907 [TBL] [Abstract][Full Text] [Related]
23. Host translation shutoff mediated by non-structural protein 2 is a critical factor in the antiviral state resistance of Venezuelan equine encephalitis virus. Bhalla N; Sun C; Metthew Lam LK; Gardner CL; Ryman KD; Klimstra WB Virology; 2016 Sep; 496():147-165. PubMed ID: 27318152 [TBL] [Abstract][Full Text] [Related]
24. Benzamidine ML336 inhibits plus and minus strand RNA synthesis of Venezuelan equine encephalitis virus without affecting host RNA production. Skidmore AM; Adcock RS; Jonsson CB; Golden JE; Chung DH Antiviral Res; 2020 Feb; 174():104674. PubMed ID: 31816348 [TBL] [Abstract][Full Text] [Related]
25. The amino-terminal domain of alphavirus capsid protein is dispensable for viral particle assembly but regulates RNA encapsidation through cooperative functions of its subdomains. Lulla V; Kim DY; Frolova EI; Frolov I J Virol; 2013 Nov; 87(22):12003-19. PubMed ID: 24006447 [TBL] [Abstract][Full Text] [Related]
26. Safety and immunogenicity of a novel trivalent recombinant MVA-based equine encephalitis virus vaccine: A Phase 1 clinical trial. Fierro C; Weidenthaler H; Vidojkovic S; Schmidt D; Gafoor Z; Stroukova D; Zwiers S; Müller J; Volkmann A Vaccine; 2024 Apr; 42(10):2695-2706. PubMed ID: 38494412 [TBL] [Abstract][Full Text] [Related]
27. The Old World and New World alphaviruses use different virus-specific proteins for induction of transcriptional shutoff. Garmashova N; Gorchakov R; Volkova E; Paessler S; Frolova E; Frolov I J Virol; 2007 Mar; 81(5):2472-84. PubMed ID: 17108023 [TBL] [Abstract][Full Text] [Related]
28. Postepizootic persistence of Venezuelan equine encephalitis virus, Venezuela. Navarro JC; Medina G; Vasquez C; Coffey LL; Wang E; Suárez A; Biord H; Salas M; Weaver SC Emerg Infect Dis; 2005 Dec; 11(12):1907-15. PubMed ID: 16485478 [TBL] [Abstract][Full Text] [Related]
29. Efficacy of Western, Eastern, and Venezuelan Equine Encephalitis (WEVEE) Virus-Replicon Particle (VRP) Vaccine against WEEV in a Non-Human Primate Animal Model. Burke CW; Erwin-Cohen RA; Goodson AI; Wilhelmsen C; Edmundson JA; White CE; Glass PJ Viruses; 2022 Jul; 14(7):. PubMed ID: 35891482 [TBL] [Abstract][Full Text] [Related]
31. Pseudotyped viruses permit rapid detection of neutralizing antibodies in human and equine serum against Venezuelan equine encephalitis virus. Kolokoltsov AA; Wang E; Colpitts TM; Weaver SC; Davey RA Am J Trop Med Hyg; 2006 Oct; 75(4):702-9. PubMed ID: 17038698 [TBL] [Abstract][Full Text] [Related]
32. Development of human antibody fragments using antibody phage display for the detection and diagnosis of Venezuelan equine encephalitis virus (VEEV). Kirsch MI; Hülseweh B; Nacke C; Rülker T; Schirrmann T; Marschall HJ; Hust M; Dübel S BMC Biotechnol; 2008 Sep; 8():66. PubMed ID: 18764933 [TBL] [Abstract][Full Text] [Related]
33. Detection of antibodies to alphaviruses and discrimination between antibodies to eastern and western equine encephalitis viruses in rabbit sera using a recombinant antigen and virus-specific monoclonal antibodies. Pässler S; Pfeffer M J Vet Med B Infect Dis Vet Public Health; 2003 Aug; 50(6):265-9. PubMed ID: 14628996 [TBL] [Abstract][Full Text] [Related]
34. Eastern equine encephalitis in Latin America. Carrera JP; Forrester N; Wang E; Vittor AY; Haddow AD; López-Vergès S; Abadía I; Castaño E; Sosa N; Báez C; Estripeaut D; Díaz Y; Beltrán D; Cisneros J; Cedeño HG; Travassos da Rosa AP; Hernandez H; Martínez-Torres AO; Tesh RB; Weaver SC N Engl J Med; 2013 Aug; 369(8):732-44. PubMed ID: 23964935 [TBL] [Abstract][Full Text] [Related]
35. Directed molecular evolution improves the immunogenicity and protective efficacy of a Venezuelan equine encephalitis virus DNA vaccine. Dupuy LC; Locher CP; Paidhungat M; Richards MJ; Lind CM; Bakken R; Parker MD; Whalen RG; Schmaljohn CS Vaccine; 2009 Jun; 27(31):4152-60. PubMed ID: 19406186 [TBL] [Abstract][Full Text] [Related]
36. An improved alphaviruses-specific RT-qPCR facilitates monitoring and prevention of alphaviruses. Xie L; Wu Y; Jiang J; Zhou H J Med Virol; 2024 Jul; 96(7):e29788. PubMed ID: 38982767 [TBL] [Abstract][Full Text] [Related]
37. PERK Is Critical for Alphavirus Nonstructural Protein Translation. Dahal B; Lehman CW; Akhrymuk I; Bracci NR; Panny L; Barrera MD; Bhalla N; Jacobs JL; Dinman JD; Kehn-Hall K Viruses; 2021 May; 13(5):. PubMed ID: 34065980 [TBL] [Abstract][Full Text] [Related]
39. The ubiquitin proteasome system plays a role in venezuelan equine encephalitis virus infection. Amaya M; Keck F; Lindquist M; Voss K; Scavone L; Kehn-Hall K; Roberts B; Bailey C; Schmaljohn C; Narayanan A PLoS One; 2015; 10(4):e0124792. PubMed ID: 25927990 [TBL] [Abstract][Full Text] [Related]